Evidence map›Paper›PMID 38429621›Full record

ArticleCanadian journal of anaesthesia = Journal canadien d'anesthesie2024

Cholinesterase activities and sepsis-associated encephalopathy in viral versus nonviral sepsis.

Charles Neu, Ricardo Esper Treml, Philipp Baumbach, Markus Engelmann, Claudius Gebhardt, Juliane Götze, Sina M Coldewey

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03620409 (Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03620409 completednot on this map

Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis

TypeobservationalSponsorJena University HospitalRan2018 to 2022Enrolled308ConditionsSepsis, Septic Cardiomyopathy, Cardiomyopathies
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Charles Neu *Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Ricardo Esper Treml *Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Philipp Baumbach *Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Markus EngelmannDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Claudius GebhardtDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Juliane GötzeDepartment of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Sina M Coldewey *Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany. sina.coldewey@med.uni-jena.de.ORCID 0000-0002-7130-0006
Jena University Hospital · DE

Funding

Bundesministerium für Bildung und Forschung 03COV07Bundesministerium für Bildung und Forschung 03Z22JN12
6 · The paper itself

Abstract

purposeThere is evidence that cholinergic imbalance secondary to neuroinflammation plays a role in the pathophysiology of sepsis-associated encephalopathy (SAE). Blood acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activities have been proposed as surrogate parameters for the cholinergic function of the central nervous system. Viral sepsis is associated with systemic inflammation and BChE has been reported to be of prognostic value in a small cohort of COVID-19 patients. Nevertheless, the prognostic value of AChE in patients with viral sepsis remains unclear.

methodsWe investigated the role of AChE and BChE activities as prognostic biomarkers of SAE and mortality in patients with viral vs nonviral sepsis enrolled in two prospective cohort studies. We quantified the AChE and BChE activities in whole blood of patients at two time points in the acute phase of viral sepsis (N = 108) and compared them with the activities in patients with nonviral sepsis (N = 117) and healthy volunteers (N = 81). Patients were observed until discharge from the intensive care unit (ICU).

resultsThree days after sepsis onset, the median [interquartile range] levels of AChE and BChE were reduced in both patients with viral sepsis (AChE, 5,105 [4,010-6,250] U·L

conclusionCholinesterase activities may be relevant prognostic markers for the occurrence of SAE and mortality in the ICU in patients with viral sepsis. STUDY REGISTRATION: This study constitutes an analysis of data from the ongoing studies ICROS (NCT03620409, first submitted 15 May 2018) and ICROVID (DRKS00024162, first submitted 9 February 2021).

Indexed as

SepsisSepsis-Associated EncephalopathyAcetylcholinesteraseButyrylcholinesteraseCholinergic AgentsCholinesterase InhibitorsHumansProspective StudiesAcetylcholinesteraseButyrylcholinesteraseCholinergic AgentsCholinesterase Inhibitorsacetylcholinesterasebutyrylcholinesterasecholinergic anti-inflammatory pathwayCOVID-19sepsis-associated encephalopathyviral sepsis

Identifiers

PMID38429621
PMCPMC10923971
OpenAlexW4392363575

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.